Metlife Inc. (MET) stock forecast and price target
Price $102.65 · data as of November 13, 2026
12-month price target
Gold marker: average target · white marker: today’s price ($102.65)
Analyst ratings
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $10.23 | +15.9% | $79.5B |
| Next fiscal year ends December 31, 2027 | $11.18 | +9.3% | $83.0B |
| Next quarter ends December 31, 2026 | $2.63 | +5.5% | $20.5B |
| Quarter after ends March 31, 2027 | $2.58 | +6.7% | $20.5B |
Consensus of the analysts covering Metlife, updated daily. In the last 30 days 9 estimates were raised and 2 lowered.
Our model vs. Wall Street
Analysts see 8.3% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Metlife’s intrinsic value about 3% above today’s market value, and it scores 2.8 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.
Frequently asked questions
What is the Metlife stock price target?
The average 12-month target from 16 analysts is $111.12, 8.3% above the current price of $102.65 Targets range from $84.00 to $131.00.
Is Metlife a buy according to analysts?
The consensus rating is “Buy” (5 strong buy, 8 buy, 4 hold, 1 strong sell). Ratings are opinions, not guarantees; this is not investment advice.
How much is Metlife expected to earn?
Analysts expect EPS of $10.23 for the fiscal year ending December 31, 2026 and $11.18 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.